Release Date: 26/02/18 16:09 Summary: ASX Appendix 4D and Half Yearly Report and Accounts Price Sensitive: Yes Download Document 357.01KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status